AJR InPractice
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow CME/SAM Credit
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, J. P.
Right arrow Articles by Chew, F. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ko, J. P.
Right arrow Articles by Chew, F. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.06.1304
AJR 2007; 188:S1-S4
© American Roentgen Ray Society

Imaging Evaluation of the Solitary Pulmonary Nodule: Self-Assessment Module

Jane P. Ko1, Catherine C. Roberts2, William G. Berger3 and Felix S. Chew4

1 Department of Radiology, New York University Medical Center, New York, NY 10016.
2 Department of Radiology, Mayo Clinic College of Medicine, Scottsdale, AZ 85259.
3 Department of Radiology, University of Arizona, Tucson, AZ 85724.
4 Department of Radiology, University of Washington, Box 354755, 4245 Roosevelt Way NE, Seattle, WA 98105.

Received October 2, 2006; revised November 22, 2006;

 
Address correspondence to F. S. Chew (fchew{at}u.washington.edu).

ARRS members earn free CME and SAM credit at www.arrs.org. Go to left-hand menu bar under Publications/Journals/SAM articles.


Abstract
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
The educational objectives for this self-assessment module are for the participant to exercise, self-assess, and improve his or her understanding of the imaging evaluation of the solitary pulmonary nodule.

Keywords: lung • solitary pulmonary nodule


INTRODUCTION
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
This self-assessment module on the imaging evaluation of the solitary pulmonary nodule has an educational component and a self-assessment component. The educational component consists of five required articles that the participant should read and one recommended article. The self-assessment component consists of 10 multiple-choice questions with solutions. All these materials are available on the ARRS Website (www.arrs.org). To claim CME and SAM credit, each participant must enter his or her responses to the questions online.


EDUCATIONAL OBJECTIVES
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
By completing this educational activity, the participant will:

  1. Exercise, self-assess, and improve his or her understanding of the imaging evaluation of the solitary pulmonary nodule.
  2. Exercise, self-assess, and improve his or her understanding of the diagnostic significance of imaging features of the solitary pulmonary nodule.


REQUIRED READING
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
(available at www.arrs.org)

  1. Ko JP. Pulmonary nodule assessment and computer-aided diagnosis. In: McAdams HP, Reddy GP, eds. Cardiopulmonary imaging: categorical course syllabus. Leesburg, VA: American Roentgen Ray Society, 2005:261-275
  2. Muhm JR, Roberts CC. AJR teaching file: solitary pulmonary nodule with enhancing rim sign. AJR 2007; 188[suppl]: S5-S6
  3. Berger WG, Erly WK, Krupinski EA, Standen JR, Stern RG. The solitary pulmonary nodule on chest radiography: can we really tell if the nodule is calcified? AJR 2001; 176:201-204
  4. Takashima S, Sone S, Li F, et al. Small solitary pulmonary nodules (≤ 1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR 2003; 180:955-964
  5. Takashima S, Sone S, Li F, Maruyama Y, Hasegawa M, Kadoya M. Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR 2003; 180:1255-1263


RECOMMENDED READING
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 
(available at www.arrs.org)

  1. Jeong YJ, Yi CA, Lee KS. Solitary pulmonary nodules: detection, characterization, and guidance for further diagnostic workup and treatment. AJR 2007; 188:57-68


INSTRUCTIONS
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 

  1. Complete the required reading.
  2. Visit www.arrs.org and go to the left-hand menu bar under Publications/Journals/SAM articles.
  3. Using your member login, order the online SAM as directed.
  4. Follow the online instructions for entering your responses to the self-assessment questions and complete the test by answering the questions online.


QUESTION 1

Which of the following is a solitary pulmonary nodule with poorly defined margins LEAST likely to be?

  1. Wegener's granulomatosis.
  2. Angioinvasive aspergillosis.
  3. Bronchioloalveolar carcinoma.
  4. Hemorrhagic metastases.
  5. Hamartoma.

 


QUESTION 2

For a solitary pulmonary nodule, which imaging feature most favors a malignancy?

  1. Central enhancement < 15 H.
  2. Round to oval shape and smooth margins.
  3. Enhancing rim of tissue surrounding a low-density center.
  4. Irregular, spiculated borders.
  5. Coarse central calcification.

 


QUESTION 3

For a well-circumscribed solitary pulmonary nodule, which CT feature most favors necrosis due to granulomatous disease rather than malignancy?

  1. Homogeneous low density on contrast-enhanced CT.
  2. Involvement of > 50% of the mass diameter.
  3. Ground-glass opacification.
  4. Intense enhancement.
  5. Density similar to water.

 


QUESTION 4

For a solitary pulmonary nodule, which pattern of calcification is associated with malignancy?

  1. A peripheral rim of calcification.
  2. Multiple conglomerate foci.
  3. Dense central calcification.
  4. Diffuse (complete) calcification.
  5. Eccentric, stippled calcification.

 


QUESTION 5

Concerning the subsolid solitary pulmonary nodule, which option is FALSE?

  1. It is associated with an increased risk of malignancy.
  2. It is suspicious for malignancy if solid components develop.
  3. It is associated with squamous cell malignancy.
  4. It can represent atypical adenomatous hyperplasia.
  5. It can represent inflammatory causes.

 


QUESTION 6

Concerning 18F-FDG PET for lung nodule evaluation, which option is FALSE?

  1. Granulomatous disease can be false-positive.
  2. Low uptake confirms a benign diagnosis.
  3. Carcinoid tumor can be false-negative.
  4. Bronchioloalveolar carcinoma can be false-negative.
  5. Lesions < 1 cm can be false-negative.

 


QUESTION 7

For solitary pulmonary nodules measuring < 1 cm, which CT feature is characteristically seen only in benign nodules?

  1. Polygonal shape.
  2. Peripheral subpleural location.
  3. Predominantly solid.
  4. Coarse spiculation.
  5. Air bronchogram.

 


QUESTION 8

For solitary pulmonary nodules measuring < 1 cm, which combination of CT features has the highest sensitivity and specificity for benign lesions?

  1. Concave margin and cavitation and satellite lesions.
  2. Predominantly solid and peripheral subpleural location or polygonal shape or 3D ratio > 1.78.
  3. Concave margin and pleural tag and coarse spiculation.
  4. Air bronchogram and pleural tag and cavitation or lobulation.
  5. Coarse spiculation and 3D ratio > 1.78 and pleural tag or air bronchogram.

 


QUESTION 9

Which statement is TRUE regarding the CT followup of indeterminant solitary pulmonary nodules?

  1. Malignant lesions often regress without treatment.
  2. Assessment of lesion growth is unrelated to lesion doubling time.
  3. Morphologic characteristics do not increase diagnostic accuracy.
  4. No change in size at follow-up indicates a benign nodule.
  5. Benign lesions may enlarge at follow-up.

 


QUESTION 10

Which of the following is TRUE regarding evaluation of a pulmonary nodule on chest radiographs?

  1. The detection of calcification on radiographs improves with increasing nodule size.
  2. Radiologists tend to overcall the presence of calcification.
  3. Stability over a 2-year interval always indicates a benign cause.
  4. Some nodules considered definitely calcified on radiographs are not calcified.
  5. Sensitivity and specificity for the presence of calcification are both greater than 80%.

 

Solution to Question 1
Poorly defined margins refer to ground-glass opacity at the borders of a nodule. Poorly defined margins have been identified in a number of entities and may correlate with hemorrhage or early cellular infiltration [1]. Thus, poorly defined margins may occur with Wegener's granulomatosis, angioinvasive aspergillosis, bronchioloalveolar carcinoma, and hemorrhagic metastases. Options A, B, C, and D are not the best responses. Hamartomas have well-defined borders. Option E is the best response.

Solution to Question 2
Several CT characteristics favor either a benign or a malignant cause for a solitary pulmonary nodule. A solitary pulmonary nodule with irregular, spiculated borders is suspicious for malignancy. Option D is the best response. A round to oval solitary pulmonary nodule with smooth margins is more characteristic of a benign process. Option B is not the best response. For nodules larger than 7 mm, the study of contrast enhancement can be used to identify those that are benign but not those that are malignant [2]. A maximal increase in attenuation of less than 15 H is indicative of a benign diagnosis, whereas an increase of 15 H or more is nonspecific. Malignant lesions and granulomas with active inflammatory changes may enhance substantially more than 15 H. Option A is not the best response. A nodule with a low-density center and a smooth enhancing rim—the "enhancing rim" sign—also favors a benign process [3]. The enhancing rim sign is seen in necrotizing granulomas. Option C is not the best response. Chronic granulomas often have coarse central calcifications. Option E is not the best response.

Solution to Question 3
Both benign and malignant solitary pulmonary nodules can have central necrosis. The CT feature that suggests necrosis caused by a necrotizing granuloma is homogeneous low density of the necrotic region [3]. Option A is the best response. Necrotic centers in malignant masses are heterogeneous in density. Malignant masses also tend to be larger than 3 cm before they show signs of necrosis. The absolute density of the necrotic region, the percentage of the mass involved, and the presence of ground-glass opacification have not been proven to be differentiating features. Options B, C, and E are not the best response. Intense enhancement of a necrotic region would not be expected in either benign or malignant masses. Option D is not the best response.

Solution to Question 4
The presence of calcification in a pulmonary nodule generally indicates a benign cause. However, malignant pulmonary nodules may show calcification, and consequently the pattern of calcification also must be taken into consideration. Additionally, the ratio of soft tissue to calcification should be considered, particularly for larger nodules, because lesions with a high percentage of soft tissue or calcifications not distributed throughout the nodule are generally considered indeterminate. A peripheral rim of calcification is considered a subtype of laminar or target pattern calcification and indicates a benign cause, typically a histoplasmoma. Option A is not the best response. Multiple conglomerate foci, also called "popcorn" calcification, are typical of a hamartoma. Option B is not the best response. The presence of central calcification is usually considered benign. However, some tumors (mucinous adenocarcinoma and carcinoid) can show central calcification, and follow-up imaging should be considered if a large soft-tissue component is present (i.e., the calcification is small relative to nodule size), if the nodule is greater than 2 cm, if the nodule shows spiculated margins, and if the calcification is not truly central. Option C is not the best response. Diffuse or complete calcification is indicative of a benign cause. Option D is not the best response. Eccentric calcification and small flecks of calcification (stippled calcification) may be observed in malignant nodules [4]. Option E is the best response.

Solution to Question 5
The subsolid nodule is a descriptor used to refer to nodules containing a component of ground-glass attenuation [5]. Groundglass attenuation is defined as an increase in lung attenuation that is not dense enough to obscure the surrounding vessels. Subsolid nodules may be of pure ground-glass attenuation (nonsolid) or of part ground-glass attenuation and part higher-density components (part solid). The subsolid nodule has primarily been associated with the spectrum of adenocarcinoma but may also occur in inflammation. Atypical adenomatous hyperplasia is now considered a precursor of adenocarcinoma and manifests as a pure grounds-glass nodule, typically less than 1 cm. Options A, B, D, and E are not the best responses. Squamous cell malignancy typically presents as a solid nodule or a mass that may contain cavitation. The subsolid nodule is not associated with squamous cell malignancy. Option C, which is false, is the best response.

Solution to Question 6
PET for diagnosing a nodule as malignant has a sensitivity and specificity of 96% and 88%, respectively [6]. False-positive findings (high standardized uptake values) may occur with various granulomatous conditions as well as with lipoid pneumonia. Option A is not the best response. Low uptake on PET can result when a lesion is beyond the resolution of PET scanners, regardless of whether the lesion is malignant or benign. Bronchioloalveolar carcinoma and carcinoid tumors have been associated with low uptake on 18F-FDG PET; therefore, low uptake does not always correlate with a benign entity. Option B, which is false, is the best response. Options C, D, and E are not the best responses.

Solution to Question 7
Of the listed high-resolution CT characteristics, polygonal shape is seen only in benign lesions [7]. Option A is the best re- sponse. The other CT findings of predominantly solid, peripheral subpleural location, coarse spiculation, and air bronchograms are seen in both benign and malignant lesions. A peripheral subpleural location is seen in 33% of benign lesions and 8% of malignant lesions. Option B is not the best response. A predominantly solid characteristic is seen in 93% of benign lesions and 20% of malignant lesions. Option C is not the best response. Coarse spiculation is seen in 20% of benign lesions and 12% of malignant lesions. Option D is not the best response. Air bronchograms are seen in 13% of benign lesions and 32% of malignant lesions. Option E is not the best response.

Solution to Question 8
The combination of CT features that is most sensitive and specific for benign lesions is predominantly solid and a peripheral subpleural location or polygonal shape or 3D ratio > 1.78 [7]. Option B is the best response. This combination showed 100% specificity and 60-63% sensitivity. The concave margin feature has a high sensitivity but a low specificity for benign lesions. Options A and C are not the best responses. Coarse spiculation, air bronchogram, satellite lesion, and cavitation do not show a statistically significant difference between benign and malignant lesions. Options D and E are not the best responses.

Solution to Question 9
Both benign and malignant lesions may increase in size at follow-up [8]. Option E is the best response. Benign lesions that can increase in size include organizing pneumonia and inflammatory pseudotumor. Malignant lesions rarely regress without treatment. Option A is not the best response. It may be difficult to assess lesion growth on follow-up studies, depending on the doubling time of the lesion. Lesions with a long doubling time have slow growth that may decrease detection on short-interval follow-up. Options B and D are not the best response. Morphologic characteristics, combined with a change in lesion size, improve diagnostic accuracy. Option C is not the best response.

Solution to Question 10
Most small (< 6-8 mm) pulmonary nodules visible on chest radiographs are diffusely calcified, since most noncalcified nodules of that size are not usually visible. However, accuracy for the detection of calcification in a pulmonary nodule is unrelated to nodule size [4]. Option A is not the best response. It has been shown that, when tested to evaluate for the presence or absence of calcification on chest radiographs, radiologists tend to hedge toward calling the nodule not definitely calcified (presumably to avoid misdiagnosing a malignancy as benign) [4]. Thus, radiologists tend to undercall the presence of calcification. Option B is not the best response. If a nodule has been stable on thoracic radiographs for more than 2 years, the current standard of care implies that a benign cause can be presumed. However, there have been case reports of malignant nodules appearing stable for more than 2 years, and substantial increases in the volume of small nodules may be missed. Caution is subsequently recommended, and older radiographs or CT scans should be pursued in this situation. Option C is not the best response. In one study with an average nodule size of 13 mm, 7% of nodules determined to be definitely calcified on chest radiographs were in fact not calcified (and thereby potentially malignant) on CT [4]. Option D is the best response. In that same study, the sensitivity (defined as the likelihood that a calcified pulmonary nodule will be called calcified) was 50%, and the specificity (defined as the likelihood that a noncalcified pulmonary nodule will be called not calcified) was 87%. Option E is not the best response.


References
Top
Abstract
INTRODUCTION
EDUCATIONAL OBJECTIVES
REQUIRED READING
RECOMMENDED READING
INSTRUCTIONS
References
 

  1. Ko JP. Pulmonary nodule assessment and computer-aided diagnosis. In: McAdams HP, Reddy GP, eds. Cardiopulmonary imaging: categorical course syllabus. Leesburg, VA: American Roentgen Ray Society,2005 : 261-275
  2. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214 : 73-80[Abstract/Free Full Text]
  3. Muhm JR, Roberts CC. AJR teaching file: solitary pulmonary nodule with enhancing rim sign. AJR 2007;188 [suppl]:S5 -S6[Free Full Text]
  4. Berger WG, Erly WK, Krupinski EA, Standen JR, Stern RG. The solitary pulmonary nodule on chest radiography: can we really tell if the nodule is calcified? AJR 2001;176 : 201-204[Abstract/Free Full Text]
  5. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS. CT screening for lung cancer: frequency and significance of partsolid and nonsolid nodules. AJR 2002;178 : 1053-1057[Abstract/Free Full Text]
  6. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188 : 487-490[Abstract/Free Full Text]
  7. Takashima S, Sone S, Li F, et al. Small solitary pulmonary nodules (≤ 1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR 2003; 180:955 -964[Abstract/Free Full Text]
  8. Takashima S, Sone S, Li F, Maruyama Y, Hasegawa M, Kadoya M. Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR 2003;180 : 1255-1263[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
E. J. Wilck
Computed Tomography Screening for Lung Cancer
Ann. Thorac. Surg., February 1, 2008; 85(2): S699 - S700.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow CME/SAM Credit
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, J. P.
Right arrow Articles by Chew, F. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ko, J. P.
Right arrow Articles by Chew, F. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS